BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

810 related articles for article (PubMed ID: 16636337)

  • 1. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.
    Sagaert X; de Paepe P; Libbrecht L; Vanhentenrijk V; Verhoef G; Thomas J; Wlodarska I; De Wolf-Peeters C
    J Clin Oncol; 2006 Jun; 24(16):2490-7. PubMed ID: 16636337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXP1 protein overexpression is associated with inferior outcome in nodal diffuse large B-cell lymphomas with non-germinal centre phenotype, independent of gains and structural aberrations at 3p14.1.
    Hoeller S; Schneider A; Haralambieva E; Dirnhofer S; Tzankov A
    Histopathology; 2010 Jul; 57(1):73-80. PubMed ID: 20579129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma.
    Banham AH; Connors JM; Brown PJ; Cordell JL; Ott G; Sreenivasan G; Farinha P; Horsman DE; Gascoyne RD
    Clin Cancer Res; 2005 Feb; 11(3):1065-72. PubMed ID: 15709173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MALT1, BCL10 and FOXP1 in salivary gland mucosa-associated lymphoid tissue lymphomas.
    Borovecki A; Korac P; Ventura RA; Perisa MM; Banham AH; Dominis M
    Pathol Int; 2007 Jan; 57(1):47-51. PubMed ID: 17199743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.
    Nyman H; Jerkeman M; Karjalainen-Lindsberg ML; Banham AH; Enblad G; Leppä S
    Eur J Haematol; 2009 May; 82(5):364-72. PubMed ID: 19141121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXP1 expression predicts polymorphic histology and poor prognosis in gastric mucosa-associated lymphoid tissue lymphomas.
    Han SL; Wu XL; Wan L; Zeng QQ; Li JL; Liu Z
    Dig Surg; 2009; 26(2):156-62. PubMed ID: 19365123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential expression of truncated isoforms of FOXP1 in primary central nervous system lymphoma.
    Courts C; Brunn A; Montesinos-Rongen M; Siemer D; Hans V; Paulus W; Wiestler OD; Küppers R; Siebert R; Deckert M
    J Neuropathol Exp Neurol; 2009 Sep; 68(9):972-6. PubMed ID: 19680146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. t(3;14)(p14;q32) results in aberrant expression of FOXP1 in a case of diffuse large B-cell lymphoma.
    Fenton JA; Schuuring E; Barrans SL; Banham AH; Rollinson SJ; Morgan GJ; Jack AS; van Krieken JH; Kluin PM
    Genes Chromosomes Cancer; 2006 Feb; 45(2):164-8. PubMed ID: 16252263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of miR-34a and its target proteins of FOXP1, p53, and BCL2 in gastric MALT lymphoma and DLBCL.
    He M; Gao L; Zhang S; Tao L; Wang J; Yang J; Zhu M
    Gastric Cancer; 2014; 17(3):431-41. PubMed ID: 24232982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations.
    Wlodarska I; Veyt E; De Paepe P; Vandenberghe P; Nooijen P; Theate I; Michaux L; Sagaert X; Marynen P; Hagemeijer A; De Wolf-Peeters C
    Leukemia; 2005 Aug; 19(8):1299-305. PubMed ID: 15944719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study.
    Thieblemont C; Briere J; Mounier N; Voelker HU; Cuccuini W; Hirchaud E; Rosenwald A; Jack A; Sundstrom C; Cogliatti S; Trougouboff P; Boudova L; Ysebaert L; Soulier J; Chevalier C; Bron D; Schmitz N; Gaulard P; Houlgatte R; Gisselbrecht C
    J Clin Oncol; 2011 Nov; 29(31):4079-87. PubMed ID: 21947824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma.
    Nakamura S; Ye H; Bacon CM; Goatly A; Liu H; Kerr L; Banham AH; Streubel B; Yao T; Tsuneyoshi M; Savio A; Takeshita M; Dartigues P; Ruskoné-Fourmestraux A; Matsumoto T; Iida M; Du MQ
    Clin Cancer Res; 2008 May; 14(10):3002-10. PubMed ID: 18445693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal instability in gastric mucosa-associated lymphoid tissue lymphomas: a fluorescent in situ hybridization study using a tissue microarray approach.
    Bernasconi B; Karamitopoulou-Diamantis E; Tornillo L; Lugli A; Di Vizio D; Dirnhofer S; Wengmann S; Glatz-Krieger K; Fend F; Capella C; Insabato L; Terracciano LM
    Hum Pathol; 2008 Apr; 39(4):536-42. PubMed ID: 18234275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression.
    Kuo SH; Chen LT; Wu MS; Kuo KT; Yeh KH; Doong SL; Yeh PY; Hsu HC; Tzeng YS; Lin CW; Lin JT; Cheng AL
    J Pathol; 2007 Feb; 211(3):296-304. PubMed ID: 17167822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXP1 expression in monoclonal gammopathy of undetermined significance and multiple myeloma.
    Korać P; Peran I; Skrtić A; Ajduković R; Kristo DR; Dominis M
    Pathol Int; 2009 May; 59(5):354-8. PubMed ID: 19432679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America.
    Remstein ED; Dogan A; Einerson RR; Paternoster SF; Fink SR; Law M; Dewald GW; Kurtin PJ
    Am J Surg Pathol; 2006 Dec; 30(12):1546-53. PubMed ID: 17122510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. API2-MALT1 fusion gene in colorectal lymphoma.
    Sakugawa ST; Yoshino T; Nakamura S; Inagaki H; Sadahira Y; Nakamine H; Okabe M; Ichimura K; Tanimoto M; Akagi T
    Mod Pathol; 2003 Dec; 16(12):1232-41. PubMed ID: 14681324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of the 5' noncoding region of the bcl-6 gene in primary gastric lymphomas.
    Go JH; Yang WI; Ree HJ
    Mod Pathol; 2001 May; 14(5):410-4. PubMed ID: 11353050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma.
    Iqbal J; Neppalli VT; Wright G; Dave BJ; Horsman DE; Rosenwald A; Lynch J; Hans CP; Weisenburger DD; Greiner TC; Gascoyne RD; Campo E; Ott G; Müller-Hermelink HK; Delabie J; Jaffe ES; Grogan TM; Connors JM; Vose JM; Armitage JO; Staudt LM; Chan WC
    J Clin Oncol; 2006 Feb; 24(6):961-8. PubMed ID: 16418494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas.
    Kuo SH; Chen LT; Yeh KH; Wu MS; Hsu HC; Yeh PY; Mao TL; Chen CL; Doong SL; Lin JT; Cheng AL
    J Clin Oncol; 2004 Sep; 22(17):3491-7. PubMed ID: 15337797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.